Lv11
50 积分 2024-01-17 加入
ASP3082, a First-in-class novel KRAS G12D degrader, exhibits remarkable anti-tumor activity in KRAS G12D mutated cancer models
3小时前
已完结
Immunoregulation by members of the TGFβ superfamily
5个月前
已完结
Receptors for the TGF-β family
6个月前
已完结
ASP3082, a First-in-class novel KRAS G12D degrader, exhibits remarkable anti-tumor activity in KRAS G12D mutated cancer models
7个月前
已完结
IL-2Rα-biased agonist enhances antitumor immunity by invigorating tumor-infiltrating CD25+CD8+ T cells
9个月前
已完结
A bispecific antibody that targets the membrane-proximal region of mesothelin and retains high anticancer activity in the presence of shed mesothelin
11个月前
已完结
皖公网安备34019202002308
